The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 12, 2022
Filed:
Dec. 28, 2018
Applicant:
Guangzhou Cellprotek Pharmaceutical Co., Ltd, Guangdong, CN;
Inventors:
Guangmei Yan, Guangdong, CN;
Yijun Huang, Guangdong, CN;
Wei Yin, Guangdong, CN;
Suizhen Lin, Guangdong, CN;
Assignee:
GUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD, Guangdong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/08 (2006.01); A61K 9/10 (2006.01); A61K 9/19 (2006.01); A61K 31/56 (2006.01); A61K 31/565 (2006.01); A61K 31/568 (2006.01); A61K 31/575 (2006.01); A61K 47/40 (2006.01); A61P 7/04 (2006.01); A61P 9/00 (2006.01); A61P 25/00 (2006.01); C07J 1/00 (2006.01); C07J 3/00 (2006.01); C07J 7/00 (2006.01); C07J 9/00 (2006.01); A61P 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/568 (2013.01); A61P 9/10 (2018.01);
Abstract
Disclosed is a use of 5α-androstane-3β,5,6β-triol, an analogue, a deuterated derivative, and a pharmaceutically acceptable salt thereof in manufacture of a medicament for the treatment of hemorrhagic stroke in a patient. The hemorrhagic stroke is intracerebral hemorrhage or subarachnoid hemorrhage.